Citius Pharmaceuticals (CTXR) Misses Q2 EPS by 11c

Citius Pharmaceuticals (NASDAQ: CTXR) reported Q2 EPS of ($0.11).

For earnings history and earnings-related data on Citius Pharmaceuticals (CTXR) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• Sandisk (SNDK) call put ratio 1.2 calls to 1 put